Frontier Pharma: Pancreatic Cancer- Identifying and Commercializing First-in-Class Innovation is a new market research publication announced by Reportstack. Pancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality rate of 10.9 deaths per 100,000 people per year. The poor prognosis of pancreatic...
More...




